Jefferies London Healthcare Conference 2023. Panelists seated left to right: LTS Lohmann CEO Bas van Buijtenen, Axplora CEO Sylke Hassel, and Bachem Holding CEO Thomas Meier (Credit: Reynald Castañeda for Endpoints News)

CD­MOs in­ves­ti­gate how to sup­port GLP-1 man­u­fac­tur­ing, phar­ma con­sid­ers sup­ply chain di­ver­si­ty: #Jef­feries23

If there were two key ideas that sprung from the CD­MO pan­el at this week’s Jef­feries Lon­don Health­care Con­fer­ence, it is that man­u­fac­tur­ers are re­view­ing how they can ex­pand in­to GLP-1s and that se­cur­ing sup­ply chains is at the back of mind for clients.

There is boom­ing de­mand for GLP-1s to the point that Sylke Has­sel, CEO of API man­u­fac­tur­er Ax­plo­ra, said that it’s akin to the surge of de­mand for Covid vac­cines dur­ing the height of the pan­dem­ic.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.